| ID: | 216 | |
|---|---|---|
| Name: | Compound 216 | |
| Description: | Original numeration in publication: 10n | |
| Labels: | Training_set, Quinazolines | |
| CAS: | ||
| InChi Code: | InChI=1S/C23H15Cl2N7O/c24-18-5-3-6-19(25)17(18)12-26-31-22(33)14-8-10-15(11-9-14)28-23-29-20-7-2-1-4-16(20)21-30-27-13-32(21)23/h1-13H,(H,28,29)(H,31,33)/b26-12+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 7.08 |
Abdallah, A. E.; Eissa, S. I.; Al Ward, M. M. S.; Mabrouk, R. R.; Mehany, A. B. M. a. E.-Z., M. A. Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation. Bioorg. Chem. 2021, 109, 104695. https://doi.org/10.1016/j.bioorg.2021.104695 |
| 6.36928 |
Eq1: VEGFR-2 inhibition (Data used to train model) |